Host response to lentiviral infection
Host response to lentiviral infection
批准号:
RGPIN-2014-04592
负责人:
Bienzle, Dorothee
金额:
$3.42万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31
中文摘要
猫很容易感染逆转录病毒(猫免疫缺陷病毒= FIV),这种病毒会导致猫患上艾滋病,就像艾滋病会导致人类患上艾滋病一样。这两种病毒都感染辅助性t淋巴细胞,诱发免疫缺陷,最终导致宿主死亡。猫感染FIV是唯一自然发生的HIV感染模型,非常适合解决在人类中难以调查的问题。感染艾滋病毒的疾病和死亡仍然是世界各地的巨大问题,但迄今为止,针对艾滋病毒的疫苗无一例外地失败。高效抗逆转录病毒疗法对治疗艾滋病毒感染是有效的,但绝大多数人无法获得。*艾滋病毒的流行源于几百年前黑猩猩将一种逆转录病毒传播给人类,最有可能是通过与狩猎有关的血液交换。鲜为人知的FIV流行源于几千年前野猫向家猫传播的逆转录病毒。在理解逆转录病毒疾病方面,一个长期存在的难题是,黑猩猩和野猫的感染不会导致疾病,而人类和猫的感染是致命的。越来越多的知识表明,宿主在接触病毒后立即采取的应对方式,可能是决定免疫缺陷和死亡是否会发生以及多快发生的最重要因素。暴露后第一天的宿主反应是由先天或预先存在的宿主反应介导的。这种宿主反应的某些成分通常会感知任何病毒并启动炎症反应,而其他因子则会感知特定的病毒,如HIV或FIV。这种病毒特异性宿主“限制因子”在遗传上的进化速度比其他宿主基因更快,在人类和猫身上似乎已经丢失或失效,但在类人猿和野猫身上仍然活跃。*在这项研究中,我们将确定为什么猫不能限制FIV复制。首先,我们检查病毒本身是否包含抑制免疫反应的因素。这将通过产生高度纯化的病毒颗粒,通过质谱分析其蛋白质,搜索数据库以识别非病毒蛋白质以及确定这些蛋白质的功能来实现。然后,我们在宿主体内检查树突状细胞(树突状细胞是第一个捕获跨越粘膜入侵的病毒的细胞)和淋巴细胞(树突状细胞是免疫缺陷发展过程中的主要病毒储存库)中哪些基因对炎症刺激作出反应。这些基因将被仔细检查是否可能与FIV相互作用,特别是与病毒结合的限制性因子内的位点将被详细描述到分子水平。然后,将克隆编码限制性因子的候选基因,在体外生产它们的蛋白质,然后进行检测,以精确确定病毒对细胞的干扰机制。最后,将解决对细胞因子抑制更敏感的病毒是否导致猫的病毒负担更低,免疫缺陷和疾病更少。*这些调查旨在确定1)宿主抗fiv因子的存在;2)对FIV生命周期和致病性的意义;3)干扰病毒感染的机制;4)这些反应与感染结果的相关性。结果将产生广泛适用于理解逆转录病毒-宿主适应和进化,以及产生新的治疗和预防靶点的见解。拟议的研究解决自然科学中的基本问题,特别是病毒学和免疫学,这可能最终对促进人类健康产生影响。NSERC是这项研究的合适资助机构。
英文摘要
Cats are susceptible to infection with a retrovirus (feline immunodeficiency virus = FIV) that causes AIDS in cats like HIV causes AIDS in humans. Both viruses infect helper T-lymphocytes, induce immunodeficiency and eventually cause death of the host. Infection of cats by FIV is the only naturally occurring model of HIV infection, and very suitable for addressing questions difficult to investigate in humans. Illness and death from infection with HIV remain enormous problems throughout the world, but vaccines against HIV to date have uniformly failed. Highly active anti-retroviral therapy is effective for treating HIV infections, but is not accessible to the vast majority of people. * The HIV epidemic arose from transmission of a chimpanzee retrovirus to humans several hundred years ago, most likely through exchange of blood associated with hunting. The lesser-known FIV epidemic arose from transmission of a retrovirus from wild cats to domestic cats several thousand years ago. A long-standing conundrum in understanding of retroviral disease is that infection in chimpanzees and wild cats does not cause disease, while in humans and cats infections are fatal. Knowledge is emerging to indicate that the manner in which the host deals immediately after exposure with the virus is probably most important for determining whether and how quickly immunodeficiency and death will occur. Host responses in the first days after exposure are mediated by innate, or pre-existing, host responses. Some components of this host response generally sense any virus and initiate an inflammatory response, while other factors sense specific viruses such as HIV or FIV. Such virus-specific host "restriction factors" evolve genetically more quickly than other host genes, and appear have become lost or ineffective in humans and cats, but remain active in apes and wild cats. * In this research we will determine why cats fail to restrict FIV replication. First, we examine whether the virus itself incorporates factors that suppress immune responses. This will be accomplished by generating highly purified virus particles, analysis of their proteins by mass spectrometry, search of databases to identify the non-viral proteins, and determination of the function of such proteins. We then examine within the host what genes respond to an inflammatory stimulus in dendritic cells (which are the first cells that capture virus invading across mucous membranes) and lymphocytes (which are the main viral reservoir during development of immunodeficiency). These genes will be scrutinized for possible interaction with FIV, and specifically the sites within the restriction factor that bind to virus will be detailed to the molecular level. Then, candidate genes that code for restriction factors will be cloned, their proteins produced in vitro, and then examined to precisely determine their mechanism of viral interference in cells. Finally, it will be resolved whether viruses with higher susceptibility to inhibition by cellular factors cause lower viral burdens and less immunodeficiency and disease in cats. * These investigations aim to determine 1) the presence of host anti-FIV factors; 2) their significance to the FIV life cycle and pathogenicity; 3) the mechanisms of interference with viral infection; and 4) the relevance of such responses to outcomes of infection. Results will yield insight widely applicable to understanding of retroviral-host adaptation and evolution, and to generation of new therapeutic and prophylactic targets. The proposed research addresses fundamental questions in the natural sciences, specifically virology and immunology, which may have eventual impact on advancing human health. NSERC is the appropriate funding agency for this research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2022
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2021
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2020
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2019
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2017
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2016
-
负责人:Bienzle, Dorothee
-
依托单位:
Veterinary Pathology
-
批准号:1218923-2009
-
项目类别:Canada Research Chairs
-
资助金额:$1.82万
-
财政年份:2015
-
负责人:Bienzle, Dorothee
-
依托单位:
Suitability of reclaimed wood bedding for horses with recurrent airway obstruction ("heaves")
-
批准号:478950-2015
-
项目类别:Engage Grants Program
-
资助金额:$1.76万
-
财政年份:2015
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2015
-
负责人:Bienzle, Dorothee
-
依托单位:
Veterinary Pathology
-
批准号:1000218923-2009
-
项目类别:Canada Research Chairs
-
资助金额:$7.29万
-
财政年份:2014
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:RGPIN-2014-04592
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.42万
-
财政年份:2014
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:217493-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.64万
-
财政年份:2013
-
负责人:Bienzle, Dorothee
-
依托单位:
Veterinary Pathology
-
批准号:1000218923-2009
-
项目类别:Canada Research Chairs
-
资助金额:$7.29万
-
财政年份:2013
-
负责人:Bienzle, Dorothee
-
依托单位:
Veterinary Pathology
-
批准号:1000218923-2009
-
项目类别:Canada Research Chairs
-
资助金额:$7.29万
-
财政年份:2012
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:217493-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.64万
-
财政年份:2012
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:380298-2009
-
项目类别:Discovery Grants Program - Accelerator Supplements
-
资助金额:$2.91万
-
财政年份:2011
-
负责人:Bienzle, Dorothee
-
依托单位:
Host response to lentiviral infection
-
批准号:217493-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$3.64万
-
财政年份:2011
-
负责人:Bienzle, Dorothee
-
依托单位:
Veterinary Pathology
-
批准号:1000218923-2009
-
项目类别:Canada Research Chairs
-
资助金额:$7.29万
-
财政年份:2011
-
负责人:Bienzle, Dorothee
-
依托单位:
Canada Research Chair in Veterinary Pathology
-
批准号:1000202707-2004
-
项目类别:Canada Research Chairs
-
资助金额:$1.82万
-
财政年份:2010
-
负责人:Bienzle, Dorothee
-
依托单位:
Veterinary Pathology
-
批准号:1000218923-2009
-
项目类别:Canada Research Chairs
-
资助金额:$5.46万
-
财政年份:2010
-
负责人:Bienzle, Dorothee
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
-
批准号:82372167
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:江继宏
-
依托单位:
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
-
批准号:82371140
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李姝娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
cGAS-STING激活IFN1反应介导噪声性耳蜗损伤机制研究
-
批准号:82371152
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:冯艳梅
-
依托单位:
PKM2调控CHIP-HSP70-BAG3复合体介导的错误折叠蛋白聚集和清除的分子机制及其在肿瘤靶向治疗中的意义
-
批准号:32000533
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:张臣良
-
依托单位:
内质网相关降解障碍诱导的胰岛Beta细胞功能衰竭机制与干预措施研究
-
批准号:32070762
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:龙乔明
-
依托单位:
长期内质网应激产生原朊病毒蛋白抵抗胰腺癌细胞凋亡的分子机制
-
批准号:32000535
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:高振兴
-
依托单位:
拟南芥辅助共激活因子ADA2b与染色质相关因子ADIP1互作参与DNA损伤响应的机制研究
-
批准号:32000493
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:江洁明
-
依托单位:
生长素响应因子(Auxin Response Factors)在拟南芥雄配子发育中的功能研究
-
批准号:31970520
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:姚小贞
-
依托单位:
组蛋白去乙酰化酶 1 调控线粒体未折叠蛋白反应的分子机制及对衰老相关疾病的应用
-
批准号:31900544
-
项目类别:青年科学基金项目
-
资助金额:15.0万元
-
批准年份:2019
-
负责人:邵丽娃
-
依托单位: